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ORIGINAL RESEARCH ARTICLE
Spirometry in Greenland: a cross-sectional study on
patients treated with medication targeting obstructive
pulmonary disease
Lasse Overballe Nielsen1*, Sequssuna Olsen2, Dorte Ejg Jarbøl3 and
Michael Lynge Pedersen1,4
1Queen Ingrid Primary Health Care Center, Nuuk, Greenland; 2Department of Pulmonology, Nordland
Hospital, Bodø, Norway; 3Research Unit of General Practice, Department of Public Health, University of
Southern Denmark, Odense, Denmark; 4Greenland Center for Health Research, Institute of Nursing and
Health Science, University of Greenland, Nuuk, Greenland
Background. Chronic obstructive pulmonary disease (COPD) is globally increasing in frequency and is
expected to be the third largest cause of death by 2020. Smoking is the main risk factor of developing COPD.
In Greenland, more than half of the adult population are daily smokers, and COPD may be common.
International guidelines recommend the usage of spirometry as a golden standard for diagnosing COPD.
The current number of spirometries performed among patients treated with medication targeting obstructive
pulmonary disease in Greenland remains unexplored.
Objective. To estimate the prevalence of patients aged 50 years or above treated with medication targeting
obstructive pulmonary disease and the extent to which spirometry was performed among them within 2 years.
Design. An observational, cross-sectional study based on the review of data obtained from electronic medical
records in Greenland was performed. The inclusion criterion was that patients must have been permanent
residents aged 50 years or above who had medication targeting obstructive pulmonary disease prescribed
within a period of 15 months prior to data extraction. A full review of electronic patient records was done
on each of the identified users of medication targeting obstructive pulmonary disease. Information on age,
gender, town and spirometry was registered for each patient within the period from October 2013 to
October 2015.
Results. The prevalence of patients treated with medication targeting obstructive pulmonary disease aged
50 years or above was 7.9%. Of those, 34.8% had spirometry performed within 2 years and 50% had a forced
expiratory volume (1 sec)/ forced vital capacity (FEV1/FVC) under 70% indicating obstructive pulmonary
disease.
Conclusion. The use of medication targeting obstructive pulmonary disease among patients over 50 years
old is common in Greenland. About one third of the patients had a spirometry performed within 2 years.
To further increase spirometry performance, it is recommended to explore possible barriers in health care
professionals’ usage of spirometry in different health care settings in Greenland.
Keywords: spirometry; COPD; Greenland; cross-sectional study; primary; practice
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C
hronic obstructive pulmonary disease (COPD) is
globally increasing in frequency and is expected
to be the third largest cause of death by 2020 (1).
COPD is frequent among smokers and former smokers,
and the prevalence increases with age. Smoking is the
main risk factor of developing COPD in the western
world (1). In Greenland, more than half of the adult
population are daily smokers (2,3). Thus, COPD may be
common in Greenland too. However, the actual preva-
lence remains unknown (4).
International guidelines recommend the usage of
spirometry as a golden standard for diagnosing COPD
(1). To distinguish between the symptoms of COPD and
other diseases and illnesses with similar symptoms, all
adults being treated with medication targeting obstructive
pulmonary disease should have a spirometry performed (1).

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Global Initiative for Chronic Obstructive Lung Disease
(GOLD) guidelines for COPD treatment recommend an
annual spirometry test for COPD patients (5). In Denmark,
the aim is that 90% of all COPD patients have had an
annual spirometry performed (6). The US COPD sur-
veillance concluded that COPD is a significant source
of morbidity and mortality and that the prevalence of
COPD patients may be underestimated due to the limited
use of spirometry in diagnosis. Furthermore, the study
recommends additional efforts in education of physicians
in management of COPD (7). Several studies have demo-
nstrated that the recommended usage of spirometry and
actual clinical practice are not always in coherence (810).
However, other studies found that the use of spirometry
can be improved in clinical practice with focus on train-
ing (9,11), and a Canadian study has shown that it is
feasible to implement a screening program using screening
questions and spirometry to identify COPD patients in
primary care (12).
The health care system in Greenland aims to provide
equal access to health care services for all residents. The
health care system faces challenges in the geographical
distances, infrastructural barriers that complicate travels
between towns and settlements, high turnover of health
care professionals and high financial expenditures on
acute evacuations of patients (13,14). A way of ensuring
coherent patient pathways might be telemedicine, which
has already been used in specific specialties such as
telepsychiatry, teleophthalmology, teleradiology and tele-
dermatology (15,16). In 2008, the telemedicine store-and-
forward solution (named Pipaluk) was implemented in
all towns and settlements with a population of at least
50 people. Using Pipaluk, it is possible to perform several
kinds of clinical testing, including spirometry (17).
However, the effects of using telemedicine in COPD
care remain unknown (18,19).
The health care system in Greenland initiated the life-
style project focusing on general prevention and quality
of care among patients with diabetes, hypertension and
COPD (2). In 2011, a study on performed spirometries
among patients treated with medication targeting obstruc-
tive pulmonary disease found a limited use of spirometry
in Greenland. It was concluded that limited use of
spirometry in the health care system represents a major
challenge in managing COPD. The study suggested an
increased focus on spirometry, including diagnosis, treat-
ment and monitoring of COPD by providing national
guidelines for documentation on electronic drug prescrip-
tions, smoking status and spirometry testing annually (4).
As a consequence of the 2011 study (4), the lifestyle
project increased focus on spirometry. All major health
care centres were equipped with spirometers that could be
used on existing computers identical to the spirometers
already used in the Pipaluk solution. This meant that
spirometry could be performed in all towns and settlements
with a population of 50 people or above using the same
spirometer and electronic program. In addition, a national
guideline for COPD and spirometry performance was
developed, including electronic documentation on pre-
scriptions, smoking status, annual spirometry and other
lifestyle factors. Teaching nurses and other health care
professionals in Greenland regarding how to use spiro-
metry was incorporated in an annual lifestyle concept
course. However, the current number of spirometries per-
formed among patients treated with medication target-
ing obstructive pulmonary disease remains unexplored,
and the effects of the implementation of telemedicine and
the initiatives by the lifestyle group are unknown.
The aim of this study was to estimate the prevalence of
patients aged 50 years or above treated with medication
targeting obstructive pulmonary disease and the extent to
which spirometry was performed among them.
Material and methods
Study design
An observational, cross-sectional study based on review
of data obtained from electronic medical records (EMRs)
in Greenland from 1 October 2013 to 1 October 2015 was
employed.
Setting
Greenland is an island with a population of approxi-
mately 56,000 people, where most people live in the 17
towns with only around 7,500 people living in the 56
settlements (20). The majority of the Greenlandic popu-
lation is of Inuit descent. The health care system is
divided into five health regions, with a regional hospital
in the largest town. Health care, including medication, is
free of charge for all permanent residents in Greenland.
One-third of the population in Greenland live in Nuuk,
the capital city, where Queen Ingrid Hospital is located.
This hospital functions as a central hospital for all of
Greenland and is the only hospital providing secondary
specialized health care (15). Since 2007, all primary
health care centres and settlement consultations have
used the same EMR. In 2014, the implementation of a
new national EMR, also including the secondary health
care at Queen Ingrid Hospital, was initiated.
Patients with COPD are most often seen at their local
primary health care centre, but patients with severe COPD
may be referred to and seen by visiting consultants in
Internal Medicine or referred to Queen Ingrid Hospital.
Study population and variables
The study included patients from the six largest towns
of Greenland, representing 68.1% (35,818/55,984) of the
entire population as of 1 January 2015 (20). The inclusion
criteria were as follows: patients must have been perma-
nent residents aged 50 years or above who had medica-
tion targeting obstructive pulmonary disease prescribed
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within a period of 15 months prior to data extraction.
Data were extracted from the EMR in both primary and
secondary health care in October 2015.
Medication targeting obstructive pulmonary disease
was defined as medications with Anatomical Therapeutic
Chemical code R03 (21). R03 medication includes both
short- and long-acting bronchodilators as well as inhaled
steroids along with other medication types for obstructive
airway diseases. A full review of electronic patient records
was done for each of the identified users of medication
targeting obstructive pulmonary disease.
Information on age, gender and spirometry was regis-
tered for each patient. Information on forced expiratory
volume (1 sec) (FEV1), forced vital capacity (FVC) and
FEV1/FVC was registered. An FEV1/FVC value under
70% was considered as pulmonary obstruction. Only
the most recent spirometry test was included and only the
best test if more than one test was performed on the same
day on the same patient. The spirometer used in the
selected towns was Midmark IQspiro† (Midmark Diag-
nostics Group, Gardena, CA, USA).
Statistical analysis
The prevalence of patients aged 50 years or above being
treated with medication targeting obstructive pulmonary
disease was estimated using the population of Greenland
as of 1 January 2015 as background population (20).
The number of performed spirometries within the 2-year
period was recorded with values of FEV1, FVC and
FEV1/FVC prior to data extraction. The chi-square test
was used to compare frequencies between gender and
towns, respectively. Estimates were calculated with 95%
confidence intervals (CI). A p-value under 0.05 was used
as the level of significance. All analyses were performed
using SPSS, Version 23 (IBM SPSS Statistics). The study
was approved by the Ethics Committee for Medical Re-
search in Greenland (No. 2015-23) and the Agency of
Health and Prevention in Greenland.
Results
In total, 782 patients aged 50 years or above were iden-
tified as having received an electronic prescription for
medication targeting obstructive pulmonary disease in
the 15-month period from July 2014 to October 2015.
The mean age of the patients was 64.1 (SD99.5); there
was no statistical significant difference between genders
(see Table I); however, the mean age was significantly dif-
ferent between Nuuk and Towns, p0.001 (see Table II).
The prevalence of patients aged 50 or above treated with
medication targeting obstructive pulmonary disease was
7.9% (95% CI: 7.48.5%) (see Table I). The prevalence of
medication use was significantly higher among women
(11.0%) than among men (5.4%), pB0.001 (see Table I).
Between Nuuk and the five towns, there was no signi-
ficant difference in prevalence of patients aged 50 or
above treated with medication targeting obstructive pul-
monary disease (p50.812; see Table II).
Table I. Prevalence of medication and proportion of spirometry performed in patients aged 50 years or above (gender)
Variables Total% (95% CI) (n/N) Women% (95% CI) (n/N) Men% (95% CI) (n/N) p
Mean age (SD) 64.1 (99.5) 63.7 (99.7) 64.6 (99.1) 0.224
Prevalence of medication use within a
15-month interval
7.9 (7.48.5%)
(782/9,853)
11.0 (10.111.9%)
(492/4,483)
5.4 (4.86.0%)
(290/5,370)
B0.001
Spirometry performed within 2 years 34.8 (31.438.2%)
(272/782)
33.3 (39.237.5%)
(164/492)
37.2 (31.742.8%)
(108/290)
0.268
FEV1/FVC under 70% 50.0 (44.155.9%)
(136/272)
41.5 (33.949.0%)
(68/164)
63.0 (53.972.1%)
(68/108)
B0.001
FEV1, forced expiratory volume (1 sec); FVC, forced vital capacity.
Table II. Prevalence of medication and proportion of spirometry performed in patients aged 50 years or above (Nuuk/towns)
Variables Total% (95% CI) (n/N) Nuuk% (95% CI) (n/N) Towns% (95% CI) (n/N) p
Mean age (SD) 64.1 (99.5) 62.8 (99.0) 65.1 (99.7) 0.001
Prevalence of medication use within a
15-month interval
7.9 (7.48.5%)
(782/9,853)
7.9 (7.18.7%)
(350/4,450)
8.0 (7.38.7%)
(432/5,403)
0.812
Spirometry performed within 2 years 34.8 (31.438.2%)
(272/782)
36.0 (31.041.0%)
(126/350)
33.8 (29.338.3%)
(146/432)
0.520
FEV1/FVC under 70% 50.0 (44.155.9%)
(136/272)
46.8 (38.155.5%)
(59/126)
52.7 (44.660.8%)
(77/146)
0.331
FEV1, forced expiratory volume (1 sec); FVC, forced vital capacity.
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Spirometry was performed in 34.8% (95% CI: 31.4
38.1%) of patients aged 50 or above and treated with
medication targeting obstructive pulmonary disease. No
statistical significant difference between genders (see
Table I) or between Nuuk and towns (see Table II) was
observed. The proportion of patients with an FEV1/FCV
value under 70% was 50% (95% CI: 44.155.9%). A
significantly higher proportion of males (63.0%, 95% CI:
53.972.1%) had an FEV1/FVC under 70% (pB0.001;
see Table I). The proportion of patients with an FEV1/
FCV value under 70% was not statistically significant
when comparing Nuuk with the five towns.
The proportions of patients tested with spirometry
within 2 years differed significantly among towns, ranging
from 22.0 to 49.0% (p0.008). There was no statistically
significant trend between age progression and FEV1/
FVC under 70% (p0.505). This was also the case
between genders: men, p0.474; women, p0.945.
Discussion
The prevalence of patients aged 50 years or above treated
with medication targeting obstructive pulmonary disease
was 7.9%. About one-third of patients had a spirometry
performed within 2 years, and half of the patients had an
FEV1/FVC under 70% indicating obstructive pulmonary
disease.
The major strength of this study was that 68% of the
entire Greenlandic population was covered and patients
were identified electronically. Still, the number of patients
was limited, and results should be taken with reservations.
Also, some prescriptions may have been done non-
electronically, leading to an underestimation of the number
of patients included. However, the use of electronic
prescriptions is standard and the easiest way to prescribe
medicine properly, which limits the risk of underestima-
tion. On the contrary, the estimate of treated patients may
be overestimated since no information about compliance
was available. Yet, with free medication and pharmacy
localized at the health care clinics, the extent of the over-
estimation is considered minimal. Similarly, it is possible
that not all performed spirometries were registered in the
EMR, leading to an underestimation of the included
spirometries. However, all performed clinical tests must be
documented by law, and a possible underestimation is
considered insignificant. It was not possible to distinguish
between COPD and asthma diagnosis in the study;
however, spirometry testing is indicated with all patients
above 50 years in treatment with medication targeting
obstructive pulmonary disease (5,22).
The prevalence of patients treated with medication
targeting obstructive pulmonary disease in this study
represents an increase of 25% compared to the prevalence
of 6.3% reported in 2011 (4). This may reflect an increase
of prescriptions on medication targeting obstructive pul-
monary disease or an improvement in using electronic
documentation. Also, the natural prevalence of obstruc-
tive pulmonary diseases may have increased. The number
of people 65 increased by 10% since 2011, which could
contribute to the rise of patients treated with medica-
tion targeting obstructive pulmonary disease (20). More
women than men were treated with medication targeting
obstructive pulmonary disease, which may reflect that
women in Greenland have more frequent contact to the
primary health care system (23). Similar results have been
found in other Nordic countries (2426).
The proportion of patients with a performed spirome-
try within 2 years in this study represents more than a
double of the proportion of 14.1% reported in 2011 (4),
indicating an increased awareness of spirometry within
the Greenlandic health care system. This could suggest an
effect of the initiatives by the lifestyle project.
This is in accordance with a study on spirometry per-
formance in primary health care from Denmark, which
reported that an educational program based on GOLD
guidelines could increase spirometry performance (11).
However, the proportion of patients tested with spiro-
metry in the present study is still lower than that of the
Denmark study. Of the patients with prescribed medica-
tion targeting obstructive pulmonary disease for the first
time in 2008 in a primary health care setting in Denmark,
about 50% had a spirometry performed (27). This study
found more spirometry performed in partnership prac-
tices compared to single-handed practices and also among
younger doctors compared to older doctors (27), indicat-
ing that the size of the primary clinic and the number
of doctors have an impact on the number of performed
spirometries. In our study, the difference among the towns
was observed underlining the importance of a primary
health care setting, which suggested room for improve-
ment in some towns. On the other hand, the limited usage
of spirometry in Greenland is not unique. A recent survey
including 12 countries across the Asia-Pacific region,
Africa, Eastern Europe and Latin America found that the
usage of spirometry when diagnosing COPD is under-
utilized as the median of performed spirometries across
the countries was 26%, which proves that spirometry
performance is a global challenge (28).
Only one-third of the patients treated with medication
targeting obstructive pulmonary disease had a spirometry
performed within 2 years. The reluctance to perform
spirometry is problematic in a population with a pre-
valence of 50% daily smokers, and COPD is most likely
underdiagnosed in Greenland (2,3). Studies from other
circumpolar areas in North America have shown similar
smoking percentages among the aboriginal people (2932).
Among the Inuit people in Canada, the prevalence of
diagnosed COPD was 10.1% (29), and the estimated
worldwide prevalence is between 5 and 10% in people
aged 40 years and above (33). Thus, increased awareness of
screening for COPD among adult smokers in Greenland
Lasse Overballe Nielsen et al.
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seems indicated as well as more public awareness of the
consequences of smoking and specific smoking cessation
programmes adapted to the Greenlandic culture (34).
In conclusion, the use of medication targeting obstructive
pulmonary disease among patients over 50 years old is
common. Despite increased awareness of COPD in the
health care system in Greenland, including national stan-
dardized spirometry equipment in all health care settings,
national guidelines, educational initiatives and written and
visual patient information, onlyone-third of the patients had
a spirometry performed within 2 years, indicating possible
barriers to perform spirometry in the Greenlandic health
care system. The Greenlandic health care system aims to
follow international standards of COPD treatment, and in
order to increase spirometry performance, it is recom-
mended to further explore health care professionals’ usage
of spirometry in different health care settings in Greenland.
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